Squarepoint
PROK icon

Squarepoint’s ProKidney PROK Stock Holding History

Squarepoint’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-111,763
Closed -$228K – 4919
2026
Q2 		$228K Sell
111,763
-99,344
-47% -$182K ﹤0.01% 3988
2026
Q1 		$378K Sell
211,107
-140,314
-40% -$298K ﹤0.01% 3535
2025
Q4 		$787K Buy
351,421
+6,845
+2% +$18K ﹤0.01% 2820
2025
Q3 		$834K Buy
+344,576
New +$917K ﹤0.01% 2833
2024
Q4 		– Sell
-17,976
Closed -$34.5K – 5406
2024
Q3 		$34.5K Buy
17,976
+1,599
+10% +$3.63K ﹤0.01% 3999
2024
Q2 		$40.3K Sell
16,377
-21,373
-57% -$57.4K ﹤0.01% 3928
2024
Q1 		$61.9K Sell
37,750
-169,932
-82% -$250K ﹤0.01% 3858
2023
Q4 		$370K Buy
+207,682
New +$445K ﹤0.01% 3222
2023
Q2 		– Sell
-25,883
Closed -$293K – 3913
2023
Q1 		$293K Buy
+25,883
New +$275K ﹤0.01% 2586
2021
Q3 		– Sell
-350,000
Closed -$3.54M – 3324
2021
Q2 		$3.54M Buy
+350,000
New +$3.54M 0.01% 889

Other funds holding PROK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Brown University
Brown University Providence, Rhode Island $147M AUM 5.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Squarepoint's PROK Position: Q3 2026 in Review

Squarepoint sold out of ProKidney (PROK) in Q3 2026, closing a stake of 111,763 shares — an estimated $228K sold.

Squarepoint first reported a position in PROK in Q2 2021 and held it in 10 quarters. The position peaked at $3.54M in Q2 2021. 41 funds tracked by Wall St. Rank hold PROK as of Q3 2026.

  • Squarepoint reported no remaining ProKidney position as of Q3 2026 after selling out during the quarter.
  • Squarepoint sold 111,763 ProKidney shares in Q3 2026, an estimated $228K.
  • Squarepoint first reported a position in ProKidney in Q2 2021 and held it in 10 quarters.
  • Squarepoint's ProKidney position peaked at $3.54M in Q2 2021.
  • 41 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.